Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Original Research
Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 25,990 | Dovepress* | 20,957+ | 1,783 | 22,740 | |
| PubMed Central* | 5,033 | 1,469 | 6,502 | ||
| Totals | 25,990 | 3,252 | 29,242 | ||
|
*Since 3 September 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar